Shamrock Pharmachemi is a part of Shamrock Group, which is involved in Contract Manufacturing, and export of APIs, Intermediates and Veterinary products for over 23 years. Over this period Shamrock has established itself as a recognizable brand promoting Indian APIs and Intermediates internationally.

The Shamrock Pharma Group is focused on providing customers high-quality APIs & Intermediates from its manufacturing & contract manufacturing facilities.

Shamrock customise the product suiting to customer and market requirements while meeting its quality standards and documentation to provide a long term supply chain for APIs.

The company has been recently acquired by SHAMROCK PHARMA GROUP and is now 100% owned by them. The new management brings in more accountability, commitment and better upgraded facilities to meet the high quality and regulatory requirements of global markets.

The company has a manufacturing record of more…

Complex Biological APIs, Starting Materials & Intermediates

Shamrock Biotech offers a focused portfolio of biological APIs, drug substances, starting materials and intermediates across anticoagulants, fertility, glycosaminoglycans, pulmonary surfactants and specialty biologicals.

Specialized Finished Dosage Forms for Critical Care, Hospital & Specialty Care

Shamrock Pharma Group offers a focused portfolio of critical-care, anti-infective, anticoagulant and specialty finished dosage forms, supported by specialized manufacturing, CMO/CDMO, technology transfer, dossier and global commercialization capabilities.